Genomenon has secured $2.5m in equity financing from all its previous investors and new contributors including H.W. Kaufman group, Invest Michigan and IrishAngels. The the Ann Arbor-based product of University of Michigan's start-up infrastructure operates an AI-supported search engine that analyses scientific publications for information on gene variants. Called Mastermind, it is intended to help doctors better diagnose patients with cancer or rare diseases, with the company stating it is now used by over 2,200 clinicians in 200 laboratories and 35 countries. Genomenon will use the funding to improve commercial development, marketing and sales, and add three people to its staff.
Genomenon has secured $2.5m in equity financing from all its previous investors and new contributors including H.W. Kaufman group, Invest Michigan and IrishAngels. The Ann Arbor-based product of University of Michigan's start-up infrastructure operates an AI-supported search engine that analyses scientific publications for information on gene variants. Called Mastermind, it is intended to help doctors better diagnose patients with cancer or rare diseases, with the company stating it is now used by over 2,200 clinicians in 200 laboratories and 35 countries. Genomenon will use the funding to improve commercial development, marketing and sales, and add three people to its staff.